| Dietary flavonoids: effects on xenobiotic and carcinogen metabolism YJ Moon, X Wang, ME Morris Toxicology in vitro 20 (2), 187-210, 2006 | 1226 | 2006 |
| Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport S Zhang, X Yang, ME Morris Molecular pharmacology 65 (5), 1208-1216, 2004 | 478 | 2004 |
| Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport S Zhang, ME Morris Journal of Pharmacology and Experimental Therapeutics 304 (3), 1258-1267, 2003 | 454 | 2003 |
| Role of monocarboxylate transporters in drug delivery to the brain N Vijay, ME Morris Current pharmaceutical design 20 (10), 1487-1498, 2014 | 389 | 2014 |
| MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells YZ Pan, ME Morris, AM Yu Molecular pharmacology 75 (6), 1374-1379, 2009 | 386 | 2009 |
| Flavonoid–drug interactions: effects of flavonoids on ABC transporters ME Morris, S Zhang Life sciences 78 (18), 2116-2130, 2006 | 368 | 2006 |
| Mechanistic determinants of biotherapeutics absorption following SC administration WF Richter, SG Bhansali, ME Morris The AAPS journal 14, 559-570, 2012 | 362 | 2012 |
| Quercetin pharmacokinetics in humans YJ Moon, L Wang, R DiCenzo, ME Morris Biopharmaceutics & drug disposition 29 (4), 205-217, 2008 | 309 | 2008 |
| Monocarboxylate transporters (SLC16): function, regulation, and role in health and disease MA Felmlee, RS Jones, V Rodriguez-Cruz, KE Follman, ME Morris Pharmacological reviews 72 (2), 466-485, 2020 | 287 | 2020 |
| Overview of the proton-coupled MCT (SLC16A) family of transporters: characterization, function and role in the transport of the drug of abuse γ-hydroxybutyric acid ME Morris, MA Felmlee The AAPS journal 10, 311-321, 2008 | 262 | 2008 |
| Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein S Zhang, X Yang, RA Coburn, ME Morris Biochemical pharmacology 70 (4), 627-639, 2005 | 231 | 2005 |
| SLC and ABC transporters: expression, localization, and species differences at the blood-brain and the blood-cerebrospinal fluid barriers ME Morris, V Rodriguez-Cruz, MA Felmlee The AAPS journal 19, 1317-1331, 2017 | 196 | 2017 |
| Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators X Wang, AW Wolkoff, ME Morris Drug metabolism and disposition 33 (11), 1666-1672, 2005 | 180 | 2005 |
| Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells S Zhang, ME Morris Pharmaceutical research 20, 1184-1191, 2003 | 173 | 2003 |
| Combined effects of multiple flavonoids on breast cancer resistance protein (ABCG2)-mediated transport S Zhang, X Yang, ME Morris Pharmaceutical research 21, 1263-1273, 2004 | 172 | 2004 |
| Effect of flavonoids on MRP1-mediated transport in Panc-1 cells H Nguyen, S Zhang, ME Morris Journal of pharmaceutical sciences 92 (2), 250-257, 2003 | 167 | 2003 |
| Gender differences in the membrane transport of endogenous and exogenous compounds ME Morris, HJ Lee, LM Predko Pharmacological reviews 55 (2), 229-240, 2003 | 164 | 2003 |
| Brain and CSF magnesium concentrations during magnesium deficit in animals and humans: neurological symptoms. ME Morris Magnesium Research 5 (4), 303-313, 1992 | 157 | 1992 |
| Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats YJ Moon, K Sagawa, K Frederick, S Zhang, ME Morris The AAPS journal 8, E433-E442, 2006 | 149 | 2006 |
| Mechanism-based pharmacodynamic modeling MA Felmlee, ME Morris, DE Mager Computational toxicology: volume I, 583-600, 2012 | 128 | 2012 |